Chester County-based Technology Company Recognized as Leader in Neurohealth Space

Business News

MALVERN, PA — Chester County-based medical technology company Neuronetics, Inc. (NASDAQ: STIM) has been named Top Non-Invasive Devices Provider in 2022 by MedTech Outlook magazine for its NeuroStar Advanced Therapy for Mental Health.

Keith J. Sullivan, President, and CEO of Neuronetics said, “We are grateful to be recognized as a trailblazer in the neurohealth space. To know that people’s lives have changed and improved because of NeuroStar confirms our technology’s capabilities of relieving the crippling symptoms of depression.”

NeuroStar was recently featured on MedicalTechOutlook.com in an article discussing the company’s advanced technology and plans to spread awareness about mental health conditions. The article also mentioned NeuroStar’s Mental Health Awareness month campaign, which is helping thousands of people, including mental health advocate and former Major League Baseball Player Drew Robinson.

Additionally, the article highlighted the recent FDA clearance to use NeuroStar as an adjunct for treating adults with obsessive-compulsive disorder (OCD). This recognition is a testament to the effectiveness of NeuroStar’s technology and its commitment to helping people live healthier lives.

Sullivan added, “This is an exciting time for us as we continue to be leaders in the neurohealth space with FDA clearance on our innovative technology. This validation shows that psychiatric conditions can indeed be treated using this platform which allows patients suffering from depression or OCD access real solutions.”

To access the full list of the Top Non-Invasive Devices Providers in 2022, visit MedTech Outlook here.

For more information on NeuroStar, please visit neurostar.com.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News.